GHK-Cu peptide: what it is, research forms and the evidence
GHK-Cu is a copper-binding tripeptide (Gly-His-Lys complexed with one copper(II) ion) found in human plasma and studied for collagen synthesis, wound repair and hair-follicle signalling. It is the compound most skincare labels mean by copper peptides. PrymaLab supplies it as GHK-Cu 50mg and GHK-Cu 100mg vials, a GHK-Cu Nasal Spray and a preloaded GHK-Cu pen for research use only.
- Sequence: Gly-His-Lys (glycyl-L-histidyl-L-lysine); the free tripeptide is C14H24N6O4, 340.4 g/mol, before copper binding.
- Class: Naturally occurring copper-binding tripeptide, isolated from human plasma by Loren Pickart in 1973.
- Studied for: Collagen and glycosaminoglycan synthesis, wound closure, hair-follicle growth, and anti-inflammatory gene expression in skin.
- Figures in the literature: Plasma GHK is about 200 ng/mL at age 20 and declines to 80 ng/mL by age 60 (Pickart and Margolina, 2018).
- Human evidence: Topical creams in 12-week facial studies; no controlled trial of injected GHK-Cu has been published.
- Storage: Lyophilised powder cold and dark; reconstituted solution is blue-violet and kept refrigerated (see the storage guide below).
- Forms at PrymaLab: GHK-CU 50MG, GHK-CU 100MG, GHK-Cu Nasal Spray, GHK-CU 3ml pen (50mg/ml).
| Form | Typical research use | PrymaLab product |
|---|---|---|
| Vial or pen (solution) | Systemic and local tissue models | GHK-CU 50MG, GHK-CU 100MG, preloaded 3ml pen |
| Topical (cream or serum) | Skin studies: collagen, elasticity, photoaged skin; the 12-week facial trials | None; vials are used to prepare research solutions |
| Nasal spray | Ready solution for intranasal research; small-peptide route with little GHK-Cu-specific data | GHK-Cu Nasal Spray |
Related: GHK-Cu storage and handling, how to verify a GHK-Cu COA, the GLOW blend that pairs GHK-Cu with BPC-157 and TB-500, and the peptide reconstitution calculator.
Also known as: copper peptide, copper tripeptide-1, Gly-His-Lys-Cu
Quick Answer: Ghk-Cu Peptide
GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine, first isolated from human plasma by Loren Pickart in 1973 and since studied in cell culture, animal wound models and topical human trials for collagen synthesis, tissue remodelling and hair-follicle signalling. This research-use-only guide covers what the molecule is, how it is thought to act, what the topical studies and the research forms cover, and what is still unproven. The review by Pickart and Margolina (2018) is the most complete open-access summary of the primary literature.
GHK-Cu and copper peptides: what the name means
GHK is the tripeptide glycyl-L-histidyl-L-lysine, three amino acids in the order Gly-His-Lys. On its own it binds copper(II) tightly, and the complex it forms with one copper ion is GHK-Cu, the form found in human plasma and the form that carries most of the published biology. The copper is not an additive; the histidine and the terminal amine hold the ion in a defined geometry, which is why the powder and its solutions are blue to violet.
When a skincare label says copper peptides, it almost always means GHK-Cu, sometimes listed as copper tripeptide-1. The plural covers a few related sequences and copper salts used in cosmetics, but the peptide with the plasma origin, the wound-repair literature and the gene-expression data is this one. On this site, GHK-Cu, copper peptide and copper tripeptide refer to the same molecule.
Peptide Research Copper Peptides Skin Science
Exploring the Benefits of GKU Peptide: The Complete GHK-Cu Guide for 2026
Article Overview
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide first isolated from human blood plasma in 1973 by researcher Loren Pickart. Backed by decades of peer-reviewed research, this copper peptide has been studied for effects on skin, hair follicles, wound repair and cellular processes. This guide covers its mechanisms of action, the study findings and the safety data.
What Is GHK-Cu Peptide?
GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. This copper peptide was first isolated from human blood plasma in 1973 by biochemist Loren Pickart, who saw that older liver cells began functioning like younger tissue when exposed to plasma from younger donors. The active factor responsible turned out to be GHK-Cu, a small peptide with a powerful affinity for copper(II) ions.
In human plasma, peptide levels average about 200 ng/mL at age 20, declining to roughly 80 ng/mL by age 60. This age-related decline correlates with visible signs of aging, including reduced collagen production, slower wound healing, and diminished skin elasticity. Also known as copper tripeptide-1 in cosmetic forms, GHK-Cu has become one of the most studied peptides in dermatology and regrowth medicine.
The peptide's unique structure allows it to chelate copper ions and deliver them safely into cells, where copper serves as an essential cofactor for many enzymes involved in collagen synthesis, antioxidant defense, and tissue remodeling. Unlike many synthetic compounds, it occurs naturally in human saliva, urine, and blood.
GHK-Cu at a Glance
| Property | Details |
|---|---|
| Full Name | Glycyl-L-Histidyl-L-Lysine Copper Complex |
| INCI Name | Copper Tripeptide-1 |
| Molecular Formula | C14H22CuN6O4 |
| Molecular Weight | 401.9 g/mol (with copper) |
| Discovery | 1973 by Loren Pickart (UC San Francisco) |
| Natural Source | Human plasma, saliva, urine |
| Plasma Level (age 20) | ~200 ng/mL |
| Plasma Level (age 60) | ~80 ng/mL |
| Key Functions | Collagen synthesis, wound healing, anti-inflammatory, antioxidant, gene modulation |
How Does GHK-Cu Work? Mechanisms of Action
Grasp how This regrowth peptide works needs examining its multifaceted natural activity. Research has identified at least five main mechanisms through which this copper peptide exerts its effects, ranging from direct collagen boost to broad-scale gene tuning affecting over 4,000 human genes.
Copper Chelation and Cellular Delivery
The glycine residue in GHK plays the main role in copper binding, creating an exceptionally stable complex with a binding constant of log10 = 16.44. This shelf life allows GHK-Cu to safely transport copper(II) ions into cells without triggering the oxidant damage that free copper often causes. Once inside the cell, copper starts essential cuproenzymes including superoxide dismutase (SOD) for antioxidant defense, lysyl oxidase for collagen cross-linking, and cytochrome c oxidase for cellular respiration.
Collagen and Extracellular Matrix Stimulation
At picomolar to nanomolar levels, GHK-Cu boosts fibroblasts to synthesize collagen, decorin (a small proteoglycan that regulates collagen architecture), and glycosaminoglycans (GAGs). This triple boost strengthens the entire extracellular matrix and connective tissue rather than just one component. Research by Maquart and colleagues showed that the tripeptide-copper complex greatly increased collagen synthesis in fibroblast cultures in vitro, providing the scientific foundation for its widespread use in anti-aging skincare.
Growth Factor Release
It boosts the release of multiple growth factors key for tissue repair and regrowth. These include vascular endothelial growth factor (VEGF) for blood vessel formation, brain-derived neurotrophic factor (BDNF) for nerve health, and bone morphogenetic protein 2 (BMP-2) for bone and cartilage repair. These growth factor findings come from cell and animal studies.
Perhaps the most notable discovery about GHK-Cu is its power to tune the expression of thousands of human genes. Studies using the Broad Institute's Connectivity Map have shown that GHK can reset the activity of over 4,000 genes toward a healthier expression pattern. It upregulates genes linked with tissue repair, antioxidant defense, and stem cell function while downregulating genes linked to swelling, tissue destruction, and fibrosis.
This genomic-level activity, mainly its impact on gene expression, helps explain why a single small peptide can produce such diverse natural effects. This genomic-level activity helps explain why a single small peptide can produce such diverse natural effects.
Metalloproteinase Regulation
This bioactive tripeptide simultaneously boosts both matrix metalloproteinases (MMPs), which break down damaged extracellular proteins, and their natural inhibitors (TIMPs). This balanced control ensures that damaged tissue is removed efficiently while new tissue formation is protected, preventing the too much scarring that occurs when either process dominates, and promoting healthy skin remodeling. This dual control distinguishes this peptide from simpler compounds that only promote building or only promote breakdown.
Copper and the matrix enzymes in fibroblast studies
The cell evidence for GHK-Cu and the extracellular matrix comes mainly from two fibroblast culture studies. Maquart and colleagues reported in 1988 that the complex stimulated collagen synthesis, with the effect starting between 1 and 10 picomolar and peaking at 1 nanomolar, and that it did not depend on any change in cell number (Maquart et al. 1988). They also noted that the GHK sequence occurs in the ฮฑ2(I) chain of type I collagen, and suggested that proteases at a wound might release the tripeptide from collagen itself (Maquart et al. 1988).
A 2000 study by Simรฉon and colleagues turned to matrix breakdown. In dermal fibroblast cultures, GHK-Cu raised MMP-2 in the conditioned medium and increased MMP-2 mRNA (Simรฉon et al. 2000). Copper ions reproduced the effect; the tripeptide without copper did not (Simรฉon et al. 2000). The complex also increased secretion of the inhibitors TIMP-1 and TIMP-2, and the authors concluded that GHK-Cu activates remodelling of the matrix as well as the production of connective tissue (Simรฉon et al. 2000). Read together, the two papers suggest that some activity attributed to GHK-Cu belongs to the copper it carries, so comparisons of GHK, GHK-Cu and a copper salt are needed to separate the two. Both are cell culture studies; neither measured what happens in a living wound.
GHK-Cu and skin: what the studies report
Skin is the best-studied area for GHK-Cu. Controlled facial studies reported measurable improvements in skin firmness, fine lines and overall texture over 8 to 12 weeks of topical application.
Collagen Production and Skin Firmness
Collagen loss begins around age 25, with the skin losing about 1% of its collagen each year thereafter. In fibroblast studies, the copper-peptide compound stimulated production of type I and type III collagen and supported elastin production, the main structural proteins responsible for skin strength and elasticity.
Fine lines and wrinkles in facial studies
The controlled facial and eye cream studies tested GHK-Cu creams on women with signs of photoaging over 12 weeks and reported improvement in fine lines. Cell studies also report faster cell turnover and proliferation, and antioxidant activity relevant to photoaging.
Can Copper Peptides Damage Skin?
Some users have reported negative experiences, leading to searches for "copper peptides ruined my skin." Reported causes include products with excessively high copper levels, combination with incompatible actives such as direct acids or high-level vitamin C, and products from unreliable manufacturers.
Can GHK-Cu Help with Hair Growth?
Copper peptides for hair growth have attracted research interest, mostly from cell and animal studies; large clinical trials are limited.
Proposed effects on hair follicles
Proposed mechanisms include collagen and extracellular matrix production around the follicle, VEGF-mediated angiogenesis in the scalp, and anti-inflammatory effects relevant to follicle miniaturization in androgenetic alopecia.
Forms used for hair
Cosmetic copper peptide products for hair are sold as topical scalp serums and shampoos.
Wound Healing and Tissue Repair with GHK-Cu
Wound healing was among the first natural activities identified for GHK-Cu, and the evidence supporting its tissue repair, skin repair, and overall wound repair capabilities is extensive. Animal studies have showed that treatment with this peptide accelerated wound closure by up to 64.5% compared to 28.2% in untreated controls, accompanied by greatly lower levels of swelling markers.
Animal Study Evidence
In a landmark study by Canapp and colleagues, full-thickness wounds in rats treated with topical GHK-Cu showed dramatically faster healing compared to vehicle-treated and untreated controls. The the treated group showed better wound contraction, accelerated granulation tissue growth, improved angiogenesis, and elevated antioxidant enzyme levels. Notably, This treatment also reduced levels of MMP-2, MMP-9, and tumor necrosis factor-alpha, all swelling markers that impede healing when elevated.
This peptide has also been shown to produce systemic healing effects. When injected into one body area (such as the thigh muscles) in animal models, it improved healing at distant sites (such as the ears), suggesting that the peptide triggers a whole-body healing response rather than only acting locally.
Diabetic Wound Healing
Biotinylated GHK-Cu incorporated into collagen wound dressings showed notable results in diabetic rat models. The treated wounds showed faster contraction, higher glutathione and ascorbic acid levels (key antioxidants), increased collagen synthesis, and greater start of fibroblasts and mast cells. These findings are very major because diabetic wounds are notoriously hard to heal due to impaired circulation and chronic swelling.
Mechanisms Behind Tissue Repair
GHK-Cu's wound healing effectiveness stems from its power to attract immune cells to the injury site, boost growth factor release (VEGF, FGF, TGF-beta), enhance collagen and GAG synthesis for new tissue scaffolding, regulate metalloproteinase activity to balance tissue breakdown and rebuilding, and reduce swelling that impedes healing. These findings come from cell culture and animal studies.
Anti-Inflammatory and Antioxidant Effects of GHK-Cu
The anti-swelling and antioxidant properties of GHK-Cu add to virtually all of its documented benefits. By silencing copper's redox activity when bound in the GHK-Cu complex, this peptide delivers copper safely while simultaneously protecting cells from oxidant damage.
Anti-Inflammatory Mechanisms
The copper compound reduces swelling through multiple pathways. It decreases the production of pro-swelling cytokines including TNF-alpha and IL-6, blocks the NF-kB signaling pathway that drives chronic swelling, and attracts control immune cells that resolve swelling responses. In models of ischemic wounds, treatment greatly reduced TNF-beta levels compared to untreated controls, creating an environment conducive to repair rather than ongoing tissue damage.
Antioxidant Protection
The copper delivered by this tripeptide serves as an essential cofactor for superoxide dismutase (SOD), one of the body's most important antioxidant enzymes. This regrowth peptide also boosts the production of glutathione, the body's master antioxidant, and elevates levels of ascorbic acid (vitamin C) in treated tissues. In these studies it acted on several antioxidant defense systems at once.
Forms of GHK-Cu: Topical, Injectable, and Oral
GHK-Cu is sold in several forms: topical cosmetic products, research powders and solutions, and oral supplements. The evidence differs by form.
Topical GHK-Cu: Creams and Serums
Topical copper peptide products represent the most accessible and widely used form. A quality copper peptide serum or cream delivers the peptide directly to the skin surface, where it penetrates to boost fibroblasts in the dermis. Serums often contain higher levels than creams, making them preferable for targeted anti-aging treatment. Look for products listing copper tripeptide-1 in their ingredient list, and check that any certificate matches the product lot and can be verified.
Research powders and solutions
Research-grade GHK-Cu is supplied as a freeze-dried powder that is dissolved in a suitable sterile diluent, or as a ready solution. In animal studies, systemic administration reached tissue beyond the skin; no controlled human trial of injected GHK-Cu has been published.
Oral GHK-Cu Supplements
Oral GHK-Cu capsules and supplements offer convenience but face uptake challenges. Peptides are often broken down by digestive enzymes before reaching systemic circulation, which limits the effectiveness of oral supply. Some manufacturers use encapsulation technologies to protect the peptide through the digestive tract, but the evidence for oral uptake remains limited compared to topical and injectable routes.
Comparison of GHK-Cu Delivery Methods
The forms differ mainly in how much evidence sits behind them. Topical serums and creams have the controlled human studies; oral capsules face digestive breakdown and low bioavailability; nasal and injected forms have no controlled human trial.
What published studies tested
| Study or model | Subject | Material | Route | Duration |
|---|---|---|---|---|
| Facial and eye cream studies cited in Pickart and Margolina (2018) (Leyden et al.) | 71 women with signs of photoaging, facial cream; 41 women, eye cream | A GHK-Cu cream; the application schedule is not stated in the review | Topical | 12 weeks in each study |
| Wound and tissue-repair models reviewed by Pickart and Margolina (2018) | Rats, mice, rabbits | GHK-Cu applied topically or locally at the wound | Topical or local | Days to weeks |
The human evidence is topical, and no controlled trial of injected GHK-Cu has been published. Concentrations for a research solution are worked out with the peptide reconstitution calculator.
What the GHK-Cu studies measured
The controlled human studies applied GHK-Cu creams to the face and eye area for 12 weeks and assessed signs of photoaging; the review that describes them does not state the application schedule (Pickart and Margolina, 2018). Animal wound studies applied GHK-Cu to the wound in gels or dressings and measured wound closure, granulation tissue, angiogenesis and antioxidant enzymes. No controlled trial of injected GHK-Cu has been published, and this page does not reproduce the regimens that practitioners and forums circulate.
Dissolving GHK-Cu in the lab
Research-grade GHK-Cu is often supplied as a freeze-dried powder that is dissolved in a suitable sterile diluent using sterile technique. Concentration is mass divided by volume: a 50 mg vial dissolved in 2 mL gives 25 mg/mL. The solution is blue to violet and is stored in the refrigerator at 2-8 degrees Celsius.
What Are the Side Effects of GHK-Cu?
Reported side effects of GHK-Cu are mostly mild and come mainly from topical use.
Common Side Effects
The most often reported side effects of GHK-Cu are mild and often resolve on their own. Topical users may experience temporary redness, mild irritation, or a tingling sensation at the use site, very during the first week of use. These local reactions are often short-lived.
Potential Concerns: Liver and Copper Accumulation
Questions about GHK-Cu side effects on the liver arise because copper is metabolized mainly through hepatic pathways. Copper load is therefore the theoretical concern at high exposure, especially in conditions of copper buildup such as Wilson's disease or in existing liver disease. No controlled trial has quantified it.
Populations without safety data
There are no safety data for pregnant or breastfeeding women. Metal-handling disorders such as Wilson's disease and hemochromatosis, and known allergies to copper compounds, are the main concerns for any copper-containing compound. No drug interaction data have been published.
Is GHK-Cu FDA Approved?
This peptide is not FDA approved as a drug for any specific medical condition. It is available as a cosmetic ingredient (copper tripeptide-1) in topical skincare products and as a research peptide. The FDA does not regulate peptides sold for research purposes with the same rigor applied to pharmaceuticals. This control status means buyers should check that the certificate of analysis matches the lot number on the vial and can be verified.
How Does GHK-Cu Compare to Other Peptides?
With dozens of research peptides available, grasp where this peptide fits in the broader landscape helps you make informed decisions. Each peptide has a different mechanism and evidence base.
GHK-Cu vs. BPC-157
While both peptides promote healing, they work through different pathways. it mainly acts through copper supply, collagen boost, and gene tuning, and most of its evidence concerns skin. BPC-157 (Body Protection Compound) focuses on gut healing, tendon and ligament repair, and nitric oxide tuning.
GHK-Cu vs. TB-500
TB-500 (Thymosin Beta-4) specializes in promoting cell migration and blood vessel formation for acute injury repair. GHK-Cu's evidence centres on skin, wound repair and gene-expression data.
Peptide Comparison Table
| Feature | GHK-Cu | BPC-157 | TB-500 |
|---|---|---|---|
| Primary Action | Copper delivery, collagen stimulation, gene modulation | Gut healing, tendon/ligament repair | Cell migration, angiogenesis |
| Delivery Forms | Topical, injectable, oral | Injectable, oral | Injectable |
| Natural Origin | Yes (human plasma) | Synthetic (from gastric juice protein) | Synthetic (from thymosin beta-4) |
| Gene Modulation | 4,000+ genes | Limited data | Limited data |
| Skin Data | Topical human studies and cell data | Minimal | Minimal |
| Hair Data | Cell and animal data | Not established | Not established |
| Research Volume | Extensive (since 1973) | Growing (since 1990s) | Moderate |
Where to buy GHK-Cu for research
Product quality varies dramatically in the peptide market, and choosing the right source directly affects both safety and results. Reputable suppliers provide a lot-matched certificate of analysis that can be verified, and transparent labeling that confirms you are getting genuine GHK-Cu at the stated level.
What to Look for When Buying
When assessing GHK-Cu products, check that the certificate of analysis (COA) matches the lot number on your vial, can be verified, and confirms purity of 98% or higher. Check that the product clearly lists the level of copper tripeptide-1 or GHK-Cu on the label. For research-grade powders, verify that the peptide has been manufactured under Good Manufacturing Practice (GMP) conditions. Avoid products with unusually low prices, as these often show compromised purity or potency.
Topical Product Selection Tips
For copper peptide serums and creams, look for products that list copper tripeptide-1 within the first third of the ingredient list, showing a meaningful level. The best copper peptide serum forms combine GHK-Cu with paired ingredients such as hyaluronic acid for hydration and peptide-stabilizing agents. Avoid forms that combine copper peptides with direct acids (AHAs, BHAs), retinoids, or high-level vitamin C, as these can destabilize the copper complex and reduce effectiveness.
Research-grade product considerations
For research-grade GHK-Cu, look for HPLC (High Performance Liquid Chromatography) purity results of 98% or higher on a certificate that matches the lot number. The product should come as a sealed, sterile freeze-dried powder. Common sizes include GHK-Cu 50 mg and 100 mg vials. Always verify proper cold-chain shipping to ensure the peptide keeps its potency during transit.
GHK-Cu at PrymaLab
Explore our copper peptide products for laboratory research. Every lot is tested in PrymaLab's own laboratory (RP-HPLC purity, LC-MS identity), and certificates can be checked at prymalab.net/testing/verify.
Shop Copper PeptidesDisclaimer: This article is for informational and educational purposes only. The data provided is not intended to diagnose, treat, cure, or prevent any disease or health condition. The compounds discussed in this article are research chemicals not approved by the FDA for human treatment use. PrymaLab sells GHK-Cu for laboratory research use only; it is not for human or veterinary use.
Key Takeaways
- GHK-Cu is a naturally occurring copper tripeptide first isolated from human plasma in 1973, with over 50 years of research behind it
- The peptide modulates 4,000+ human genes, stimulates collagen synthesis, and promotes wound healing at the cellular level
- Controlled facial studies reported improvements in signs of photoaging over 12 weeks of topical use
- Hair-follicle effects come from cell and animal data; large clinical trials are limited
- Sold as topical cosmetic products, research powders and solutions, and oral supplements; the human evidence is topical
- Reported side effects are mostly mild; copper load is the theoretical concern in Wilson's disease and liver disease
- Check that the certificate of analysis matches the lot number on your vial, can be verified, and shows 98%+ purity
What is GHK-Cu peptide and how does it work?
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide found in human blood plasma. It works by chelating copper ions and delivering them safely into cells, where copper starts enzymes responsible for collagen synthesis, antioxidant defense, and tissue repair. The peptide also tunes the expression of over 4,000 human genes toward healthier patterns.
What are the main benefits of GHK-Cu peptide?
Studies have reported increased collagen and glycosaminoglycan production in fibroblast cultures, improvements in signs of photoaging in 12-week topical facial studies, faster wound closure in animal models, and antioxidant and anti-inflammatory effects in cell and animal studies. It is used in cosmetic skincare and in laboratory research.
What amounts of GHK-Cu have studies used?
The controlled human studies applied GHK-Cu creams for 12 weeks, and the review that describes them does not state the application schedule; animal wound studies applied it locally. No controlled trial of injected GHK-Cu has been published, and research material carries no dosing recommendation.
Can GHK-Cu peptide help with hair growth?
Cell and animal studies suggest effects on follicles through collagen and matrix production, VEGF-mediated scalp circulation and reduced inflammation. Large clinical trials are limited.
What are the side effects of GHK-Cu?
GHK-Cu side effects are often mild. Topical users may experience temporary redness or irritation. Injectable data are sparse, so systemic tolerability is not characterised, and copper load is the theoretical concern in Wilson's disease, liver conditions and copper handling disorders.
Is GHK-Cu FDA approved?
No, GHK-Cu is not FDA approved as a drug. It is available as copper tripeptide-1 in cosmetic skincare forms and as a research peptide. Products sold for research purposes are not subject to pharmaceutical-grade control, so buyers should check that the certificate matches the lot number on the vial and can be verified.
Can copper peptides ruin your skin?
When used correctly at appropriate levels, copper peptides rarely cause skin damage. Reports of negative experiences often involve excessively concentrated products, combining copper peptides with incompatible actives like vitamin C or strong acids, or using low-quality forms.
What has GHK-Cu been shown to do in skin studies?
In fibroblast cultures it increased collagen and glycosaminoglycan synthesis; in 12-week topical facial studies, signs of photoaging improved; and in cell and animal studies it showed antioxidant and anti-inflammatory activity.
How is GHK-Cu dissolved in the lab?
Freeze-dried GHK-Cu is dissolved by slowly adding a suitable sterile diluent to the vial. For a 50 mg vial, 2 mL gives 25 mg/mL. The powder is allowed to dissolve without shaking, and the solution is stored refrigerated at 2-8 degrees C.
Scientific References
- Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nature. 1973;243(124):85-87. PubMed
- Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988. doi:10.1163/156856208784909435
- Maquart FX, Pickart L, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex GHK-Cu2+. FEBS Letters. 1988;238(2):343-346. PubMed
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108. doi:10.1155/2015/648108
- Canapp SO, et al. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Vet Surg. 2003;32(6):515-523. doi:10.1111/j.1532-950x.2003.00515.x
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. doi:10.3390/ijms19071987
- Simeon A, et al. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex GHK-Cu(2+). J Invest Dermatol. 2000;115(6):962-968. doi:10.1046/j.1523-1747.2000.00166.x
- Arul V, Kartha R, Jayakumar R. A therapeutic approach for diabetic wound healing using biotinylated GHK incorporated collagen matrices. Life Sciences. 2007;80(4):275-284. doi:10.1016/j.lfs.2006.09.018
- Lau SJ, Sarkar B. The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a growth-modulating tripeptide from plasma. Biochem J. 1981;199(3):649-656. doi:10.1042/bj1990649
- Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci. 2009;31(5):327-345. doi:10.1111/j.1468-2494.2009.00490.x
Frequently Asked Questions
What is GHK-Cu?
GHK-Cu is a naturally occurring tripeptide, glycyl-L-histidyl-L-lysine, bound to one copper(II) ion. It was isolated from human plasma by Loren Pickart in 1973 and is studied in cell culture and animal models for collagen and glycosaminoglycan synthesis, wound closure, hair-follicle signalling and anti-inflammatory gene expression. Research suppliers sell it as a lyophilised powder, a nasal spray or a preloaded pen.
Is GHK-Cu the same as copper peptides?
In practice, yes. Copper peptides on a skincare label almost always means GHK-Cu, sometimes written as copper tripeptide-1. The plural exists because a few related sequences and copper salts are also used in cosmetics, but the peptide with the plasma origin, the wound-repair literature and the gene-expression data is GHK-Cu. This guide uses the two terms for the same molecule.
What did the GHK-Cu studies apply?
The human data are topical: the 12-week studies Pickart and Margolina describe applied a GHK-Cu facial cream to 71 women with signs of photoaging and an eye cream to 41 women, with the application schedule not stated in the review. Animal wound studies applied GHK-Cu in gels or dressings to the wound. For injection there is no published controlled trial.
Topical vs systemic GHK-Cu: which has more evidence?
Topical. The controlled human studies of GHK-Cu are cream and serum trials on photoaged skin, and the animal wound-repair literature is largely local application. Systemic administration has no published controlled trial behind it, so its systemic effects are inferred from cell-culture and animal data rather than measured in people.
What are the side effects of GHK-Cu in studies?
The human safety record is topical and short: the facial and eye cream studies described by Pickart and Margolina ran 12 weeks, and no controlled trial has run longer. Injectable data are sparse, so systemic tolerability is not characterised; the theoretical concerns are copper load at high exposure and local reactions, neither of which has been quantified in a controlled trial. Research protocols treat GHK-Cu as an unapproved compound with an incomplete safety record.
What is GHK-Cu peptide?
GHK-Cu is a copper-binding peptide studied for skin repair, collagen support, wound healing, inflammation control, and hair-related pathways. In skincare, copper peptides may support firmness, elasticity, and barrier repair. Product quality, concentration, and correct use matter because copper peptide formulas can vary widely.
What are the main benefits discussed in this guide?
This guide explains the main research-backed benefits, practical use considerations, safety concerns, and limitations related to GHK-Cu peptide.
Is GHK-Cu peptide safe?
The human safety record is limited to short topical studies, and source quality matters. The article explains known side effects and the limits of the safety data.
Who should read this GHK-Cu peptide guide?
This guide is written for readers researching peptide mechanisms, study findings, side effects, and evidence quality.
Formats stocked for the compounds in this article
GKP BLEND: GKP BLEND 70MG and GKP BLEND 70mg/ml preloaded 3ml pen. Every listing is supplied for laboratory research use with a batch certificate of analysis.
